Skip to content

Meditron: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Meditron

BE 0461.538.767
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€22,383
2024 · €40,158-€17,775
Equity
€433,685
2024 · €412,301+€21,384
Cash
€42,050
2024 · €73,000-€30,950
Balance sheet total
€488,085
2024 · €484,119+€3,966

Largest movements

2024 to 2025
Assets
  • Current investments +€61,620

    up €61,620 (+20.1%), from €307,003 to €368,623

  • Cash -€30,950

    down €30,950 (-42.4%), from €73,000 to €42,050

    mainly Current investments (-€61,620) and Other debts (-€14,112)

  • Receivables within one year -€12,443

    down €12,443 (-23.5%), from €52,854 to €40,411

    of which Trade receivables: -€11,455

  • Stocks and contracts -€9,508

    down €9,508 (-22.4%), from €42,532 to €33,024

Equity and liabilities
  • Reserves +€21,384

    up €21,384 (+6.1%), from €350,301 to €371,685

    of which Distributable reserves: +€21,384

  • Other debts -€14,112

    down €14,112 (-23.4%), from €60,329 to €46,217

  • Tax, wage and social debts -€6,148

    no longer reported in 2025 (was €6,148)

Income statement
  • Gross operating margin -€21,591

    down €21,591 (-39.0%), from €55,325 to €33,734

  • Taxes -€8,546

    down €8,546 (-42.7%), from €20,009 to €11,463

  • Financial income -€5,698

    down €5,698 (-48.1%), from €11,853 to €6,155

    of which Non-recurring financial income: -€7,215

  • Depreciation -€1,167

    down €1,167 (-19.8%), from €5,894 to €4,727

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €40,158
Gross operating margin -€21,591
Depreciation +€1,167
Other operating charges -€109
Financial income -€5,698
Financial charges -€90
Taxes +€8,546
Result 2025 €22,383

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€31,643
Investment -€61,594
Financing -€999
Cash 2024 €73,000
Net result for the year +€22,383
Depreciation +€4,727
Stocks and contracts +€9,508
Receivables within one year +€12,443
Trade debts +€2,812
Tax, wage and social debts -€6,148
Other debts -€14,112
Accrued charges and deferred income +€30
Investment in fixed assets (net) +€26
Current investments -€61,620
Contributions, distributions and other -€999
Cash 2025 €42,050
Every line side by side 45 lines
Line Code 2024 2025 Change %
Total assets 20/58 €484,119 €488,085 +€3,966 +0.8%
Fixed assets 21/28 €8,730 €3,977 -€4,753 -54.4%
Tangible fixed assets 22/27 €8,704 €3,977 -€4,727 -54.3%
Land and buildings 22 €3,836 €3,260 -€576 -15.0%
Plant, machinery and equipment 23 €494 €355 -€139 -28.1%
Furniture and vehicles 24 €4,374 €362 -€4,012 -91.7%
Financial fixed assets 28 €26 - -€26
Current assets 29/58 €475,389 €484,108 +€8,719 +1.8%
Stocks and contracts in progress 3 €42,532 €33,024 -€9,508 -22.4%
Stocks 30/36 €42,532 €33,024 -€9,508 -22.4%
Amounts receivable within one year 40/41 €52,854 €40,411 -€12,443 -23.5%
Trade receivables 40 €51,472 €40,017 -€11,455 -22.3%
Other amounts receivable 41 €1,382 €394 -€988 -71.5%
Current investments 50/53 €307,003 €368,623 +€61,620 +20.1%
Cash at bank and in hand 54/58 €73,000 €42,050 -€30,950 -42.4%
Total equity and liabilities 10/49 €484,119 €488,085 +€3,966 +0.8%
Equity 10/15 €412,301 €433,685 +€21,384 +5.2%
Contributions 10/11 €62,000 €62,000 = 0.0%
Capital 10 €62,000 €62,000 = 0.0%
Issued capital 100 €62,000 €62,000 = 0.0%
Reserves 13 €350,301 €371,685 +€21,384 +6.1%
Non-distributable reserves 130/1 €24,839 €24,839 = 0.0%
Legal reserve 130 €24,839 €24,839 = 0.0%
Distributable reserves 133 €325,462 €346,846 +€21,384 +6.6%
Amounts payable 17/49 €71,818 €54,400 -€17,418 -24.3%
Amounts payable within one year 42/48 €70,458 €53,010 -€17,448 -24.8%
Trade debts 44 €3,981 €6,793 +€2,812 +70.6%
Suppliers 440/4 €3,981 €6,793 +€2,812 +70.6%
Taxes, remuneration and social security 45 €6,148 - -€6,148
Taxes 450/3 €6,148 - -€6,148
Other amounts payable 47/48 €60,329 €46,217 -€14,112 -23.4%
Accrued charges and deferred income 492/3 €1,360 €1,390 +€30 +2.2%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €5,894 €4,727 -€1,167 -19.8%
Other operating charges 640/8 €775 €884 +€109 +14.1%
Gross operating margin 9900 €55,325 €33,734 -€21,591 -39.0%
Operating profit (loss) 9901 €48,656 €28,123 -€20,533 -42.2%
Financial income 75/76B €11,853 €6,155 -€5,698 -48.1%
Recurring financial income 75 €4,638 €6,155 +€1,517 +32.7%
Non-recurring financial income 76B €7,215 - -€7,215
Financial charges 65/66B €342 €432 +€90 +26.3%
Recurring financial charges 65 €342 €432 +€90 +26.3%
Profit (loss) for the period before taxes 9903 €60,167 €33,846 -€26,321 -43.7%
Income taxes 67/77 €20,009 €11,463 -€8,546 -42.7%
Profit (loss) for the period 9904 €40,158 €22,383 -€17,775 -44.3%
Profit (loss) for the period to be appropriated 9905 €40,158 €22,383 -€17,775 -44.3%

Source: filed annual accounts (NBB), financial years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 9 October 2026 via checked.be.